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Background
Although the rapid reperfusion by coronary artery
bypass graft (CABG) surgery has significant success and
it can cause decrease in mortality and morbidity rate,
but this reperfusion paradoxically can cause ionic and
metabolic damage that lead to myocardial damage and
myocytes death. We examined whether perioperative
exogenous erythropoietin (EPO) can reduce myocardial
damage by reducing troponin I and creatine kinase
(CKMB) level.
Methods
43 patients randomly divided into two groups. Patients in
erythropoietin group were treated by common medical
therapies and CABG plus 700 IU/kg erythropoietin (PD
Poietin, puyeshdaroo, Iran), intravenously infusion, exactly
5 min after termination of cross clamp: at the start of
reperfusion and patients in control group were treated by
common medical therapies and CABG surgery plus 10 cc
normal saline as placebo. CKMB and Troponin I, were
measured before and 8 hours after surgery. Echocardiogra-
phy was performed 4days after surgery in all patients.
Results
No differences were detected between EPO and control
group in change of troponin from before to after surgery
(1.41 ± 2.09 vs. 1.79 ± 1.42 with P = 0.49). There were no
significant differences between change of CKMB from
before to after surgery in EPO and control group
(20.59 ± 17.51 vs. 11.57 ± 14.46 with P = 0.07). Also Wall
motion score index (WMSI) level, 4 days after operation
was nearly the same in erythropoietin and control groups.
(1.08 ± 0.09 vs. 1.07 ± 0.10 with P= 0.83).
Conclusions
In our study no inversely correlation were detected
between infusion of erythropoietin and change of Tro-
ponin I and CKMB after CABG surgery. Erythropoietin
had no effects on reduction of remodeling and stunning
of ventricular septum or improving ventricular function
in early postoperative period.
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